Skip to content

Follow us

Return to mob menu
Author

Kara Mackenzie

Published

28th June 2021

Category
Funding

British Heart Foundation - Translational Awards

To support the development of technologies from the PoC stage to being ready for commercial market for the benefit of human cardiovascular health.

Value: Up to £750k

Closing Date: 13th September 2021

Summary:

To support the development of technologies from the PoC stage to being ready for commercial market for the benefit of human cardiovascular health.

The scheme covers any type of technology, including:

  • novel therapeutics;
  • drug repurposing;
  • devices;
  • surgical techniques;
  • diagnostics;
  • imaging technologies;
  • digital solutions;
  • cell therapy and regenerative medicine.

We use cookies to personalise content and ads, to provide social media features and to analyse our traffic. For more information read our Privacy Notice and Cookies Policy.

Click Continue if you consent to use all non-essential cookies or choose your own cookie settings.